A phase II study evaluating the feasibility of a 5-week cycle of S-1 plus irinotecan (IRIS) in patients with advanced and recurrent colorectal cancer.

Hata, Taishi; Fukunaga, Mutsumi; Murata, Kohei; Uemura, Yoshio; Fukuzaki, Takayuki; Ota, Hirofumi; Ohue, Masayuki; Ohnishi, Tadashi; Tanaka, Nobuo; Takemasa, Ichiro

doi:10.1007/s00280-013-2143-8

A phase II study evaluating the feasibility of a 5-week cycle of S-1 plus irinotecan (IRIS) in patients with advanced and recurrent colorectal cancer.

NobleIDNI4P03W74R91S53

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/9DA166FE.svg?ark=w1%2F20260517%2F9DA166FE&value=id)](https://nobleid.org/work/w1/20260517/9DA166FE)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A phase II study evaluating the feasibility of a 5-week cycle of S-1 plus irinotecan (IRIS) in patients with advanced and recurrent colorectal cancer.

NobleIDNI4P03W74R91S53

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/9DA166FE.svg?ark=w1%2F20260517%2F9DA166FE&value=id)](https://nobleid.org/work/w1/20260517/9DA166FE)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work